Horizons Clinical Research Center, LLC is categorized under Commercial Medical Research in Denver, CO and active since 2007.
Horizons Clinical Research Center, LLC was established in 2007, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number by the NAICS.
If you are seeking more information, feel free to contact Bill Arnold at the company’s single location by writing to 4495 Hale Parkway, Denver, Colorado CO 80220 or by phoning (303) 399-4067. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Horizons Clinical Research Center, LLC |
| Contact Person: | Bill Arnold |
| Address: | 4495 Hale Parkway, Denver, Colorado 80220 |
| Phone Number: | (303) 399-4067 |
| Website Address: | horizonscrc.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| Share This Business: |
Horizons Clinical Research Center, LLC was started in 2007 to provide professional Commercial Medical Research under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Bill Arnold for inquiries that concern Horizons Clinical Research Center, LLC by calling the company number (303) 399-4067, as your correspondence is most welcome. Additionally, the physical location of the single location of Horizons Clinical Research Center, LLC can be found at the coordinates 39.73378,-104.93548 as well as the street address 4495 Hale Parkway in Denver, Colorado 80220.
For its online presence, you may visit Horizons Clinical Research Center, LLC’s website at horizonscrc.com and engage with its social media outlets through on Twitter and on Facebook.